A Study of ABT-751 in Patients With Renal Cell Cancer

Sidney Kimmel Comprehensive Cancer Center, Baltimore

US Oncology Inc Raleigh Hematology Oncology Clinic, Cary

US Oncology Inc Cancer Centers of the Carolinas, Greenville

US Oncology Inc Cancer Centers of Florida, P.A., Orlando

US Oncology Inc Ocala Oncology Center, Ocala

US Oncology Inc Florida Cancer Institute, New Port Richey

West Cancer Clinic, Memphis

US Oncology Inc Dayton Oncology & Hematology P.A., Kettering

US Oncology Inc Cancer Care Accociates-Mercy Campus, Oklahoma City

US Oncology Inc Tyler Cancer Center, Tyler

US Oncology Inc Rocky Mountain Cancer Centers, Denver

Arizona Cancer Research Center, Tucson

UCLA School of Medicine, Los Angeles

Clinical Trials + Research Associates, Montebello

US Oncology Inc Northwest Cancer Specialists, Vancouver

US Oncology Inc Cancer Care Northwest-North, Spokane

Oncology Hematology Group of South Florida, Miami

McGill University, Montreal

University of Chicago Medical Center, Chicago

Vanderbilt Ingram Cancer Center, Nashville

B.C. Vancouver Cancer Agency, Vancouver

Queen Elizabeth II Health Science Centre, Halifax

McMaster University, Hamilton